Published in J Clin Microbiol on December 01, 1994
Zygomycetes in human disease. Clin Microbiol Rev (2000) 9.80
Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev (2011) 1.82
Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol (2003) 1.38
Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol (2006) 1.36
Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. J Clin Microbiol (2010) 1.13
Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis. Antimicrob Agents Chemother (2002) 1.05
Mucormycosis spondylodiscitis after lumbar disc puncture. Eur Spine J (2005) 0.91
Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections. J Clin Pathol (1996) 0.91
Femur osteomyelitis due to a mixed fungal infection in a previously healthy man. J Clin Microbiol (1999) 0.86
Massive bone loss from fungal infection after anterior cruciate ligament arthroscopic reconstruction. Clin Orthop Relat Res (2009) 0.82
Invasive Apophysomyces variabilis infection in a burn patient. J Clin Microbiol (2012) 0.80
Osteoarticular Infections Caused by Non-Aspergillus Filamentous Fungi in Adult and Pediatric Patients: A Systematic Review. Medicine (Baltimore) (2015) 0.79
Zygomycosis caused by Apophysomyces elegans. J Clin Microbiol (1985) 1.72
Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol (1988) 1.67
Zygomycosis. Infect Dis Clin North Am (1989) 1.47
Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment. N Engl J Med (1978) 1.46
The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol (1980) 1.36
Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol (1990) 1.31
Apophysomyces elegans as an agent of zygomycosis in a patient following trauma. J Med Vet Mycol (1992) 1.31
Invasive infection due to Apophysomyces elegans in immunocompetent hosts. Clin Infect Dis (1993) 1.30
Opportunistic mycotic osteomyelitis: bone infections due to Aspergillus and Candida species. Medicine (Baltimore) (1977) 1.27
Wound zygomycosis (mucormycosis) in otherwise healthy adults. Am J Med (1988) 1.22
Zygomycotic necrotizing fasciitis caused by Apophysomyces elegans. J Clin Microbiol (1993) 1.22
Localized mucormycosis following intramuscular corticosteroid. Case report and review of the literature. Am J Med Sci (1978) 1.16
Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol (1992) 1.14
Saksenaea vasiformis osteomyelitis. J Clin Microbiol (1987) 1.01
Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis (1994) 0.98
Rhinocerebral mucormycosis: premortem diagnosis and therapy. Arch Intern Med (1979) 0.96
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
[Anthrax due to deliberate infection]. Ned Tijdschr Geneeskd (2001) 3.33
[Choice of antibiotics in uncomplicated cystitis; application of 'system of objectified judgement analysis' (SOJA) method]. Ned Tijdschr Geneeskd (1999) 2.97
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]. Ned Tijdschr Geneeskd (2004) 2.55
The challenge of Lyme disease: tired of the Lyme wars. Neth J Med (2011) 2.20
Patient satisfaction after total knee arthroplasty: a comparison between subjective and objective outcome assessments. J Arthroplasty (2001) 2.16
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest (1996) 2.03
[Belt and suspenders. Medical jargon in The Netherlands and Flanders]. Ned Tijdschr Geneeskd (1994) 1.97
NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype. Neth J Med (2005) 1.89
[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia]. Ned Tijdschr Geneeskd (2005) 1.85
Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol (2000) 1.80
Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg (1999) 1.76
Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis (2000) 1.70
Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol (1990) 1.66
Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med (2005) 1.65
Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol (1999) 1.64
Atypical mycobacterial infection of the parotid gland. J Pediatr Surg (1990) 1.60
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect (2012) 1.54
Aneurysmal bone cysts treated by curettage, cryotherapy and bone grafting. J Bone Joint Surg Br (1997) 1.53
[Female patient with cutaneous anthrax in Belgium]. Ned Tijdschr Geneeskd (2001) 1.53
Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome. Eur J Clin Invest (2005) 1.52
Circulating cytokines as mediators of fever. Clin Infect Dis (2000) 1.51
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res (1999) 1.49
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Fas-FasL interactions modulate host defense against systemic Candida albicans infection. J Infect Dis (1999) 1.47
[Clinical results and costs due to improved antibiotics policies]. Ned Tijdschr Geneeskd (1999) 1.43
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
[Improved diagnostics in invasive aspergillosis and systematic monitoring in patients at high risk of infection]. Ned Tijdschr Geneeskd (2005) 1.41
[Amphotericin B: the end of an era]. Ned Tijdschr Geneeskd (2004) 1.40
[Invasive aspergillosis: epidemiology, diagnosis and therapy]. Ned Tijdschr Geneeskd (1994) 1.39
The midline cervical cleft. J Pediatr Surg (1991) 1.37
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol (1999) 1.27
Keratin expression in cervical cancer. Am J Pathol (1992) 1.26
The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors: functional results at several postoperative intervals. Arch Orthop Trauma Surg (2000) 1.25
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone. J Surg Oncol (2000) 1.22
Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am J Pathol (1992) 1.20
The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood (1997) 1.18
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol (2000) 1.14
Voriconazole salvage treatment of invasive candidiasis. Eur J Clin Microbiol Infect Dis (2003) 1.14
SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med (2012) 1.14
Triple osteotomy of the pelvis for acetabular dysplasia: results at 8 to 15 years. J Bone Joint Surg Br (1997) 1.11
Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur J Clin Invest (2004) 1.11
Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis (2004) 1.07
Treatment of benign and low-grade malignant intramedullary chondroid tumours with curettage and cryosurgery. Eur J Surg Oncol (1998) 1.06
Late malignant transformation of biopsy proven benign synovial chondromatosis: an unexpected pitfall. Histopathology (2000) 1.06
[Toxic shock-like syndrome caused by streptococci]. Ned Tijdschr Geneeskd (1999) 1.06
Q fever in the Netherlands from 2007 to 2010. Neth J Med (2010) 1.05
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol (2000) 1.05
Was isolation of Veillonella from spinal osteomyelitis possible due to poor tissue perfusion? Med Hypotheses (2004) 1.05
Helicobacter cinaedi bacteremia associated with localized pain but not with cellulitis. Clin Infect Dis (1996) 1.03
Lethal Escherichia coli and Salmonella typhimurium endotoxemia is mediated through different pathways. Eur J Immunol (2001) 1.03
Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis (2005) 1.03
Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest (2001) 1.02
Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. J Antimicrob Chemother (2003) 1.02
Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol (1999) 1.02
Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur Cytokine Netw (2002) 1.02
Quality of life in bone tumor patients comparing limb salvage and amputation of the lower extremity. J Surg Oncol (1992) 1.02
Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest (2000) 1.01
Fibrous dysplasia of bone: management and outcome of 20 cases. J Surg Oncol (2001) 1.01
Femoral bone loss in total knee arthroplasty. A review. Acta Orthop Belg (1999) 1.00
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother (2000) 1.00
Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat. Biomaterials (1999) 0.99
Meniscal tissue regeneration in porous 50/50 copoly(L-lactide/epsilon-caprolactone) implants. Biomaterials (1997) 0.99
Use of porous polyurethanes for meniscal reconstruction and meniscal prostheses. Biomaterials (1996) 0.98
Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis. J Immunol Methods (1999) 0.98
Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis (1995) 0.97
Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes (Lond) (2008) 0.96
Cytokeratins in smooth muscle cells and smooth muscle tumours. Histopathology (1988) 0.95
Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B. J Antimicrob Chemother (1998) 0.95
Giant cell tumor of bone: oncologic and functional results. J Surg Oncol (1994) 0.95
Acetabular coverage of the femoral head after triple pelvic osteotomy: no relation to outcome in 51 hips followed for 8-15 years. Acta Orthop Scand (1999) 0.95
Gait and electromyographic analysis of patients recovering after limb-saving surgery. Clin Biomech (Bristol, Avon) (2000) 0.94
The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology (1998) 0.93
Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol (2008) 0.93
Differential roles of interleukin-18 (IL-18) and IL12 for induction of gamma interferon by staphylococcal cell wall components and superantigens. Infect Immun (2001) 0.93
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. Clin Microbiol Infect (2012) 0.93
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia. Eur J Clin Microbiol Infect Dis (2007) 0.93
FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging (2006) 0.93
Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases. Scand J Immunol (2005) 0.92
Traumatic instability of the proximal tibiofibular joint. Injury (1981) 0.92
Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy. Eur J Clin Microbiol Infect Dis (2011) 0.92
Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice. Infect Immun (1997) 0.92
Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation. J Antimicrob Chemother (1992) 0.91
Osteosarcoma: oncologic and functional results. A single institutional report covering 22 years. J Surg Oncol (1999) 0.91
Late pulmonary metastases from chondroblastoma of the distal femur. A case report. Acta Orthop Scand (1990) 0.91
Ultrastructural and immunohistochemical study of epithelioid hemangioendothelioma of bone: coexpression of epithelial and endothelial markers. Ultrastruct Pathol (1990) 0.89
Monitoring during cryosurgery of bone tumors. J Surg Oncol (1997) 0.89
Meniscal repair by fibrocartilage? An experimental study in the dog. J Orthop Res (1992) 0.88
Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways. Immunology (1998) 0.88